Showing results (71-80 of 96) with videos related to
Sort By:
Pageof 10
Anales De Medicina Interna (Madrid, Spain : 1984)|February 1, 1989
[Primary biliary cirrhosis in Navarra]F Borda, M P Huarte, J M Zozaya, et al.Annals of Diagnostic Pathology|June 23, 2020
Quantitative analysis of p16 methylation in Barrett's carcinogenesisE Chueca, A Valero, C Hördnler, et al.Alimentary Pharmacology & Therapeutics|April 13, 2011
Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in EuropeA Lanas, L Aabakken, J Fonseca, et al.Revista Espanola De Enfermedades Digestivas|August 1, 1992
[Gastric emptying of solids, acid secretion and tobacco in duodenal ulcer]M Montoro, F Gomollón, F Sopeña, et al.Gastroenterologia Y Hepatologia|May 3, 2002
[Effect of exogenous administration of platelet-derived growth factor and epidermal growth factor on duodenal ulcer healing in rats treated with indomethacin]A Pérez Aisa, F Sopeña Biarge, E Arceiz Gonzalo, et al.Alimentary Pharmacology & Therapeutics|October 22, 2009
Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinomaP Jiménez, E Piazuelo, C Cebrian, et al.International Journal of Immunogenetics|September 17, 2005
No allelic variant associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer diseaseM A Garcia-Gonzalez, P H M Savelkoul, R Benito, et al.Revista Clinica Espanola|June 1, 1994
[A iatrogenic pathology study in an internal medicine service]A L Sampéreiz Legarre, M T Rubio Obanos, F Escolar Castellón, et al.Clinical and Experimental Immunology|November 25, 2003
Association of interleukin 1 gene family polymorphisms with duodenal ulcer diseaseM A García-González, A Lanas, P H M Savelkoul, et al.Current Cancer Drug Targets|December 15, 2011
Characterization of the prostaglandin E2 pathway in a rat model of esophageal adenocarcinomaE Piazuelo, S Santander, C Cebrián, et al.Pageof 10